Korea Development Bank ended negotiations with Korea Investment Holdings over the sale of KDB Life Insurance, halting the acquisition process three months after the preferred bidder was selected. The parties failed to agree on pre-acquisition capital expansion and the allocation of related costs after KDB Life’s K-ICS ratio fell to 78.7% at the end of June, below financial authorities’ recommended level of 130%. The breakdown marks the seventh failed sale attempt since the process began in 2014. KDB has not finalized follow-up plans, including a possible resale, and will review alternatives while continuing efforts to normalize KDB Life’s management.